Introducing

Optilight by Lumenis

Change the way you treat your dry eye disease

New Insight Family Eyecare elevates dry eye care with OptiLight by Lumenis. A safe, non-invasive under-eye light treatment for the area directly below the eye that gently uses light pulses to heat the meibomian glands and restores your quality of life.

How Optilight Works

The meibomian glands are oil glands along the edge of the eyelids where your eyelashes are found. The main job of these glands is to make oil for the outside layer of tears to stop the tears from drying up too quickly.

OptiLight by Lumenis helps the health of your eyes in multiple ways. It loosens meibomian gland blockages, reduces and relieves inflammation, and improves tear break-up time alleviating the irritating symptoms of dry eye. It’s the breakthrough in eyecare that can get you back to having stable, comfortable vision.

OptiLight is the only IPL FDA – approved treatment with patented OPT technology for the management of dry eye disease.

Each effective and easy session takes only 10- 15 minutes and significantly relieves dry eye symptoms including:

Boost Tear break up time (the amount of time it takes for your tears to evaporate)

Decrease pro-inflammatory mediator levels

Destroy abnormal blood vessels that support inflammation

Reduce the amount of Demodex mites and bacteria living around your eyes.

Improves meibomian gland functionality

You don’t have to live with dry, red, or irritated eyes anymore! We have the next generation of innovation – a treatment that will bring back your high quality of life. Ask your doctor at New Insight Family Eyecare if OptiLight is a good choice for you.

To start the Optilight treatment, please consult with our doctors in any one of our locations near you.

Please note, Optilight treatment may not be covered by your insurance.

Visit one of our locations for Optilight Treatment Today!

 

 

 

 

 

1320 West Main Street Waterbury, CT 06708

Phone: (203) 755-4941
Fax 🖷: (203) 573-8372
Email: [email protected]

Hours

Sunday Closed
Monday 8am-5pm
Tuesday 8am-5pm
Wednesday 8am-6pm
Thursday 8am-5pm
Friday 7am-3pm
Saturday Closed

 

 

 

 

 

67 Waterbury Road Prospect, CT 06712

Phone: (203) 758-4447
Fax 🖷: (203) 573-8372
Email: [email protected]

Hours

Sunday Closed
Monday 8am-6pm
Tuesday 8am-5pm
Wednesday 8am-5pm
Thursday 8am-5pm
Friday 7am-3pm
Saturday Closed

 

 

 

 

1449 Old Waterbury Road Suite 304 Southbury, CT 06488

Phone: (203) 267-2020
Fax 🖷: (203) 267-2021
Email: [email protected]

Hours

Sunday Closed
Monday 8am-5pm
Tuesday 8am-5pm
Wednesday 8am-5pm
Thursday 8am-5pm
Friday 8am-5pm
Saturday Closed

 

 

20 Waterside Drive Suite 102 Farmington, CT 06032

Phone: (860) 674-0307
Fax 🖷: 860-677-2766
Email: [email protected]

Hours

Sunday Closed
Monday 8am-1pm
Tuesday 8am-5pm
Wednesday 8am-5pm
Thursday 9am-6pm
Friday 8am-4pm
Saturdays
Closed

OptiLight by Lumenis is a cutting-edge, FDA-approved treatment specifically designed for managing dry eye disease, particularly related to Meibomian Gland Dysfunction (MGD). Here’s a detailed look at what the OptiLight procedure entails, its benefits, and considerations to determine if it’s the right choice for you.

Overview and Benefits

OptiLight employs Intense Pulsed Light (IPL) technology to address the root causes of dry eye symptoms. This non-invasive treatment works by delivering precise pulses of light below the eyes, which helps improve the functionality of the meibomian glands, reduces inflammation, and manages the bacterial load on the skin around the eyes. The procedure is notable for increasing tear breakup time, reducing demodex mites and bacteria around the eyes, and eliminating inflammation-contributing blood vessels.

Each session of the OptiLight treatment is brief, typically lasting about 10-15 minutes, with a recommended course of 4 sessions spaced over several weeks. The procedure is designed to be gentle, with minimal discomfort and no significant downtime, allowing patients to return to their daily activities immediately after treatment.

Safety and Effectiveness

OptiLight has been clinically validated and is celebrated for its safety and effectiveness in managing symptoms of dry eye. It is particularly beneficial for those suffering from MGD, a common condition where blockages in the eyelid’s oil glands lead to rapid tear evaporation and dry eye symptoms. Since OptiLight is non-invasive, it carries a very low risk of complications and does not involve any risks associated with infections.

Suitability

While OptiLight offers significant benefits, it’s not suitable for everyone. It is typically not recommended for individuals taking certain medications that increase light sensitivity, those with active acne in the treatment area, or individuals prone to keloid scarring. A comprehensive consultation with an eye care professional is essential to assess individual suitability for the treatment.

Practical Considerations

After completing the initial treatment cycle, patients may opt for maintenance sessions every 6 to 24 months, depending on individual needs and the advice of their eye care provider. The ongoing management helps sustain the improvements in dry eye symptoms over the long term.

OptiLight by Lumenis represents a significant advancement in the management of dry eye disease, providing a safe, effective, and non-invasive option for those struggling with this often debilitating condition. If you are considering this treatment, discussing it with a qualified eye care professional can help you understand how OptiLight can be tailored to your specific needs and whether it is the right option for your eye health goals.

For more in-depth information, Book an Appointment or you can visit the official Lumenis OptiLight page.